IV Bags: Fluid Types and Institutional Stocking

For a hospital, infusion clinic, or EMS supply chain, “IV bags” is not one line item. It is three genuinely distinct drug products in similar-looking flexible containers, stocked in at least four different bag sizes, each with its own par level, shelf life, and mix-up risk. This guide covers the procurement-relevant side of that: what the common fluid types actually are and how they’re clinically differentiated at a level useful for stocking decisions, what bag sizes exist and why, and what institutional buyers need to build into a stocking and receiving process. Choosing which fluid, rate, and volume a specific patient receives is a clinical decision made by a prescriber and pharmacy — this page does not attempt to make or guide that decision. What it covers is the procurement question: what to keep on the shelf, in what sizes, and how to avoid stocking practices that create clinical risk.

Where to source this: LAC (lac.us), CASRAI’s sister medical-supply operation, stocks a range of IV bags across common fluid types and sizes for institutional buyers who want to review current catalog options alongside the selection criteria below.

The three fluid types every general stock carries

The overwhelming majority of general medical-surgical and emergency stock is built around three crystalloid solutions. They are not interchangeable, and their clinical distinctness is exactly why a procurement team needs to understand the difference — ordering the wrong one, or letting them become visually confusable at the point of use, is a real patient-safety failure mode, not a hypothetical one.

Fluid	Composition	Tonicity	Typical role
0.9% Sodium Chloride (“normal saline,” NS)	154 mEq/L sodium, 154 mEq/L chloride, no dextrose	Isotonic	General volume replacement, medication dilution/carrier fluid, wound and device flushing
5% Dextrose in Water (D5W)	50 g/L dextrose, no electrolytes	Isotonic on infusion but behaves as a free-water source once dextrose is metabolized	Free-water repletion, a compatible diluent/carrier for many IV medications
Lactated Ringer’s (LR, Hartmann’s solution)	130 mEq/L sodium, 109 mEq/L chloride, 28 mEq/L lactate, plus potassium and calcium	Isotonic	Balanced-electrolyte volume replacement, common surgical and trauma resuscitation fluid

The clinically load-bearing distinctions a stocking decision needs to respect: NS carries no potassium or calcium and won’t correct an electrolyte deficit LR would; D5W has no sodium at all, so it is not a resuscitation fluid despite looking like “just another isotonic bag” on the shelf; LR contains calcium, which is why it is generally avoided as a diluent for blood products and for medications with known calcium incompatibilities (ceftriaxone is the most cited example). None of that is a procurement judgment call — it’s the reason clinical and pharmacy staff specify fluid type explicitly on every order, and why a stocking system that makes it easy to grab the wrong one is a real risk, not a labeling nicety.

Beyond the core three

Most facilities also carry a smaller rotating set of secondary formulations, generally in lower par quantities:

• 0.45% Sodium Chloride (“half-normal saline”) — hypotonic, used for free-water repletion in patients who need some sodium but not isotonic volume.
• Dextrose/saline combinations (D5 1/2NS, D5NS) — used where both caloric/free-water support and sodium are needed simultaneously, common in pediatric and maintenance-fluid contexts.
• Balanced multi-electrolyte solutions (Plasma-Lyte, Normosol, and similar branded formulations) — closer to human plasma electrolyte composition than LR or NS; increasingly stocked in ICUs and ORs as an alternative resuscitation fluid.

A facility’s pharmacy and therapeutics committee, not the purchasing function, decides which secondary formulations make the formulary — procurement’s job is sourcing reliably against that decided list, not expanding it independently.

Bag size: matching container volume to how the fluid is actually used

Bag size is a procurement decision with real cost and waste implications, and the common sizes map to distinct use cases rather than being interchangeable “big or small” options:

• 50–100 mL — minibags, used almost exclusively as an IV piggyback (IVPB) carrier for intermittent medication doses (antibiotics, most commonly), not for volume replacement.
• 250 mL — a middle-ground size used for shorter maintenance infusions, some medication carriers, and pediatric volumes where a 500 mL or 1000 mL bag would represent an unnecessary overfill risk.
• 500 mL — a common general medical-surgical maintenance and moderate-resuscitation size.
• 1000 mL — the standard large-volume bag for sustained maintenance infusions and larger-volume resuscitation, and the size most commonly kept in EMS and emergency-department bulk stock.

Stocking the wrong size mix is a real cost problem, not just an inconvenience: over-stocking 1000 mL bags for a unit that mostly runs antibiotic piggybacks means routine waste of unused fluid (and disposal cost) every time a bag is spiked for a small IVPB dose; under-stocking 1000 mL bags in an ED or EMS context means staff improvising with multiple smaller bags during a resuscitation. Pulling actual usage data by size — not just by fluid type — before setting par levels catches this before it becomes a recurring waste line.

Container material: a procurement-relevant detail, not just packaging

Most IV bags are manufactured from either PVC (historically plasticized with DEHP) or non-PVC alternatives (polyolefin or similar). This is a genuine sourcing distinction: DEHP-plasticized PVC containers have been the subject of extended clinical and regulatory scrutiny over leaching into lipid-containing or long-dwell-time infusates, and many pediatric, neonatal, and lipid/TPN formularies now specify non-PVC or DEHP-free containers as a standing requirement rather than a preference. If your facility’s formulary has a DEHP-free requirement for any patient population, that needs to be a purchasing specification checked against the actual bag, not assumed from the fluid type alone — the same fluid is commonly available in both container types from different manufacturers. See our extractables and leachables in single-use systems guide for the broader procurement framework around container-material safety data.

What is DEHP?

DEHP (di(2-ethylhexyl) phthalate) is a man-made chemical, a colorless liquid with a slight odor, that is added to plastics to make them flexible. The U.S. Agency for Toxic Substances and Disease Registry (ATSDR, part of CDC) lists medical tubing and blood storage bags among the items that can contain it. The National Toxicology Program’s Report on Carcinogens describes DEHP as a phthalate ester used mainly as a plasticizer in polyvinyl chloride (PVC), and names blood and intravenous solution bags, catheters and tubing for dialysis and parenteral solutions among its medical-device uses.

It matters in a supply context because a plasticizer is not part of the polymer chain. The same NTP profile identifies medical procedures as a primary route of potential human exposure and notes that people treated with DEHP-containing medical products can have high exposure, with newborn infants of particular concern; it also records FDA’s concern about aggregate exposure from repeated procedures, which often occur in neonatal intensive-care settings. NTP lists DEHP as reasonably anticipated to be a human carcinogen based on sufficient evidence from experimental animal studies, and FDA’s guidance on phthalates in drug products states that DEHP has been shown to be a developmental and reproductive toxicant in laboratory animals while the human data are less clear. These are hazard statements from the agencies, not a ruling on any specific bag, and whether a particular patient receives a particular container is a decision for the facility’s clinical and pharmacy staff.

What “DEHP-free” means when you read a bag specification

“DEHP-free” is a statement about the container’s plasticizer: the bag material does not use DEHP to stay flexible. It is not a statement about the fluid inside, and it is not the same thing as “PVC-free.” A bag can be PVC with a different plasticizer, or a non-PVC film that needs no plasticizer of this kind. Both can be sold as DEHP-free, so the label alone does not tell a buyer which material it is.

• Identify the exact product, not the fluid. The same fluid at the same volume is commonly offered in more than one container type, often under different NDCs. Record the material and plasticizer statement from the manufacturer’s labeling or package insert against the specific NDC on your formulary.
• Ask the manufacturer for the claim in writing. A catalog icon or a one-word listing is a marketing statement; the labeling and the manufacturer’s technical documentation are the controlled source.
• Check the whole fluid path, not only the bag. Administration sets and tubing are separate products and are a separate material question; see the infusion supplies and pump selection guide.
• Keep the requirement tied to your policy. Which patient populations require DEHP-free containers is set by the facility’s pharmacy and therapeutics committee and clinical policy. FDA’s own guidance notes that its CDRH issued recommendations on minimizing exposure to PVC devices containing DEHP and on high-risk procedures; those recommendations are the starting point for that internal policy, not a substitute for it.
• Prevent substitution at the dock. A DEHP-free item that is replaced by a look-alike conventional item after a backorder defeats the specification. Write “no substitution without pharmacy review” into the purchasing record for flagged NDCs, and segregate those items in storage so they are not mixed with conventional stock.

Institutional stocking: par levels, look-alike risk, and receiving checks

A few practices specific to this category are worth building into a standing procurement process rather than leaving to individual judgment at receiving or restocking time:

• Treat NS, D5W, and LR as a look-alike/sound-alike (LASA) set. Unlabeled or similarly-labeled flexible bags of different fluids sitting side-by-side on a shelf or in a code cart is a documented medication-error pattern that patient-safety organizations including ISMP have specifically flagged — the fix is procurement- and storage-level, not just a training reminder: physically separate the three fluid types on shelving, use manufacturer bags with distinct overwrap coloring or bold, high-contrast fluid-name labeling where available, and avoid bulk-storing look-alike sizes of different fluids in adjacent bins.
• Check overwrap and port integrity on receiving. IV fluid bags are sterile drug products; a torn or breached overwrap or a compromised injection port is a rejection at receiving, not a “use it anyway” judgment call at the bedside.
• Track lot numbers and expiration by fluid AND size, not just by fluid type — a facility running FEFO (first-expired, first-out) rotation needs size-level granularity or it will end up expiring 250 mL stock while 1000 mL of the same fluid rotates fine.
• Build supply resilience into par levels for this category specifically. Large-volume IV fluids are manufactured by a small number of producers at a small number of plants, which has made this category unusually exposed to single-site disruption — a 2024 hurricane that damaged a major U.S. manufacturing facility triggered a months-long national conservation period for basic saline and other LVP fluids, with hospitals rationing bag sizes and substituting oral or alternate-route hydration where clinically appropriate. A category this concentrated on the supply side warrants a documented backup-supplier plan and slightly deeper par levels than a pure just-in-time model would otherwise suggest.

Regulatory basics that affect how you order

Unopened, manufacturer-sealed IV fluid bags are FDA-regulated drug products (large-volume parenterals), ordered by NDC like any other pharmaceutical — not medical devices, and not something a general medical-surgical purchasing catalog can substitute across manufacturers without a pharmacy-verified equivalent NDC. USP compounding standards (USP <797>) become relevant once a facility’s pharmacy adds anything to the bag (potassium, additive medications, etc.), turning it into a compounded sterile preparation with its own beyond-use dating — that determination and the resulting BUD are a pharmacy responsibility, not a procurement one, but stocking depth for pre-additive base fluid should account for pharmacy’s compounding volume, not just floor-stock draw.

Related CASRAI guides

This guide covers fluid-bag selection and stocking specifically. For the delivery-side supplies used alongside these bags, see our guide to infusion supplies and pump selection (administration sets, tubing, and pump platform choice) and our IV catheter gauge selection reference (venous access device sizing). Saline used for wound and surgical irrigation is a related but procedurally distinct product line — see our wound and surgical irrigation supplies guide rather than substituting IV-labeled bags for irrigation use. For the broader equipment category, see the lab equipment pillar.

Frequently asked questions

Can normal saline and lactated Ringer’s be used interchangeably?

No. They differ in electrolyte content — LR contains potassium and calcium that NS does not — and in compatibility (LR’s calcium content is a known incompatibility issue with certain medications and with blood products). Which fluid a given patient receives is a clinical decision, not a stocking substitution.

Why does bag size matter if the fluid inside is the same?

Smaller bags (50–250 mL) are typically spiked once for a single intermittent dose or short infusion and the remainder discarded; larger bags (500–1000 mL) are used for sustained infusions where the whole volume is expected to run. Stocking the wrong size mix for how a unit actually uses fluid creates either routine waste or under-supply during high-acuity moments.

Do all IV bags need to be DEHP-free?

No — but specific patient populations (commonly neonatal, pediatric, and lipid/TPN patients) are frequently placed on a DEHP-free requirement by facility policy. Confirm your formulary’s requirement and verify it against the actual container material on the product you’re sourcing, not just the fluid type.

What should a receiving check look for on IV fluid bags specifically?

Intact overwrap, an unbreached injection port, correct fluid type and volume against the packing list, and lot/expiration data legible and consistent with the outer case labeling. Any bag with a compromised overwrap or port should be rejected at receiving, not held for bedside judgment.

What is DEHP in an IV bag?

DEHP is a phthalate plasticizer added to PVC to make it flexible. ATSDR lists medical tubing and blood storage bags among the products that can contain it, and the National Toxicology Program names blood and intravenous solution bags, catheters and tubing. That is why some formularies specify containers made without it.

What does “DEHP-free” mean on an IV bag?

It means the container material does not use DEHP as its plasticizer. It does not by itself say whether the bag is PVC or non-PVC, and it says nothing about the fluid. Confirm the claim against the manufacturer’s labeling for the exact NDC you buy.

Is a DEHP-free bag the same as a PVC-free bag?

No. PVC-free describes the base polymer; DEHP-free describes one plasticizer. Verify which claim a product actually makes before writing either into a purchasing specification.

Sources

• ATSDR, ToxFAQs for Di(2-ethylhexyl)phthalate (DEHP): https://www.atsdr.cdc.gov/toxfaqs/tfacts9.pdf (checked 2026-10-31)
• National Toxicology Program, Report on Carcinogens profile, Di(2-ethylhexyl) Phthalate: https://ntp.niehs.nih.gov/sites/default/files/ntp/roc/content/profiles/diethylhexylphthalate.pdf (checked 2026-10-31)
• FDA, Guidance for Industry: Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products: https://www.fda.gov/files/drugs/published/Limiting-the-Use-of-Certain-Phthalates-as-Excipients-in-CDER-Regulated-Products_pdf.pdf (checked 2026-10-31)